Results 171 to 180 of about 63,667 (225)

Efficacy and safety of tenofovir amibufenamide in patients with chronic hepatitis B: a real-world clinical study. [PDF]

Front Med (Lausanne)
Fan R, Fan H, Tan L, Zhang J, Ai L.
europepmc   +1 more source

Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. [PDF]

PLoS One
Sequera-Arquelladas S, Vivancos MJ, Vinuesa D, Collado A, Santos IL, Sorni P, Cabello-Clotet N, Montero M, Font CR, Terron A, Galindo MJ, Martinez O, Ryan P, Omar-Mohamed M, Albendín-Iglesias H, Javier R, Romero A, Vallecillos CG, Calleja MÁ, Hidalgo-Tenorio C.   +19 more
europepmc   +1 more source

Low Bone Mineral Density in Men Living with HIV on Tenofovir Antiretroviral Therapy: A Cross-Sectional Exploratory Study from a Malaysian Tertiary Hospital. [PDF]

Trop Med Infect Dis
Daud MR, Periyasamy P, Chin KY, Kori N, Zainulabid UA, Qian Yew S, Mohammad Kazmin NE, Khee Cheong X.   +7 more
europepmc   +1 more source

Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis. [PDF]

Sci Rep
Sattayalertyanyong O, Bandidniyamanon W, Limsrivilai J, Chotiyaputta W, Nimanong S, Tanwandee T.   +5 more
europepmc   +1 more source

Virologic, immunologic, and metabolic outcomes and mortality in people with HIV on bictegravir/emtricitabine/tenofovir alafenamide fumarate versus dolutegravir-based antiretroviral therapies: a retrospective multicenter cohort study in China. [PDF]

Lancet Reg Health West Pac
Wu X, Ma P, Ruan L, Chen Y, Wang R, Song Y, Cai Y, Chen F, Zhang L, Fitzpatrick T, Li B, Wu G, Meng X, Fan S, Qiao Y, Gao Y, Hong Z, Zhang T, Zou M, Wang L, Fu Y, Su B, Zou J, Wang H, Zou H.   +24 more
europepmc   +1 more source

Lenacapavir as pre-exposure prophylaxis for HIV prevention. [PDF]

Cochrane Database Syst Rev
Ebrahim S, Gloeck N, Adam Z, Tatz G, Nel J, Sinxadi PZ, Dawood H, Kredo T, Cohen K.   +8 more
europepmc   +1 more source

Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies. [PDF]

J Infect Dis
Cox S, Andreatta K, Hendricks MR, Li J, Kintu A, Brown LB, Carter CC, Callebaut C.   +7 more
europepmc   +1 more source

Bone Health in People Living with HIV: From Pathophysiology to Practical Management. [PDF]

Infect Chemother
Joo EJ.
europepmc   +1 more source

Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue. [PDF]

Einstein (Sao Paulo)
Zanardo LW, Izabel LDS, Hamada LM, Carvalho MB, Silva PAGOE, Joaquim HDG, Santoro S, Festuccia WT, Magdalon J.   +8 more
europepmc   +1 more source